SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-17-148349
Filing Date
2017-04-28
Accepted
2017-04-28 16:32:01
Documents
8
Period of Report
2017-06-08
Effectiveness Date
2017-04-28

Document Format Files

Seq Description Document Type Size
1 DEF 14A d316345ddef14a.htm DEF 14A 510440
2 GRAPHIC g316345g38r58.jpg GRAPHIC 25687
3 GRAPHIC g316345g61c12.jpg GRAPHIC 58102
4 GRAPHIC g317405g11y77.jpg GRAPHIC 26592
5 GRAPHIC g317405g21j11.jpg GRAPHIC 24658
6 GRAPHIC g317405g56z83.jpg GRAPHIC 16586
7 GRAPHIC g317405g57f70.jpg GRAPHIC 22487
8 GRAPHIC g317405g98q07.jpg GRAPHIC 27964
  Complete submission text file 0001193125-17-148349.txt   790604
Mailing Address 99 HAYDEN AVENUE SUITE 390 LEXINGTON MA 02421
Business Address 99 HAYDEN AVENUE SUITE 390 LEXINGTON MA 02421 (781) 357-2333
Pulmatrix, Inc. (Filer) CIK: 0001574235 (see all company filings)

IRS No.: 461821392 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36199 | Film No.: 17796109
SIC: 2834 Pharmaceutical Preparations